Related Experiment Video
Updated: Jun 20, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
[Nutrition and oncogeriatry].
1Service de Nutrition et d'Oncologie Digestive, CRLC Val d'Aurelle-Paul Lamarque, Parc Euromédecine, 34298 Montpellier cedex 5, France. psenesse@valdorel.fnclcc.fr
Summary
Severe malnutrition in oncogeriatric patients significantly worsens outcomes. Early nutritional screening and tailored interventions, including dietary counseling and appropriate artificial nutrition, are crucial for improving patient survival and quality of life.
Area of Science:
- Oncology
- Geriatrics
- Nutrition Science
Context:
- Oncogeriatric patients face heightened risks from severe malnutrition, including increased morbidity, mortality, infections, and treatment toxicities.
- French guidelines mandate systematic screening and management of malnutrition in this vulnerable population.
- Radiotherapy and chemotherapy introduce specific nutritional challenges and considerations.
Purpose:
- To outline evidence-based recommendations for nutritional management in oncogeriatric patients.
- To emphasize the importance of systematic nutritional screening and intervention.
- To guide the appropriate use of dietary counseling, oral supplementation, enteral, and parenteral nutrition.
Summary:
- Severe malnutrition in oncogeriatric patients is linked to poor outcomes; systematic screening and nutritional care are essential.
- Dietary counseling is recommended for malnourished patients, especially those undergoing radiotherapy or radiochemotherapy.
- Oral supplementation has specific indications, while enteral nutrition is preferred over parenteral nutrition due to reduced infectious complications.
Impact:
- Implementing these nutritional strategies can mitigate treatment-related toxicities and improve quality of life.
- Appropriate artificial nutrition, when indicated, can enhance patient outcomes and survival.
- Guidelines for artificial nutrition use, considering performance status and prognosis, are critical for effective care.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...